Evotec
Pui Loke is an accomplished Group Leader at Evotec, with a career spanning from March 2002 to the present. Pui has held several positions within the company, including Group Leader in Molecular Architecture and Medicinal Chemistry, Team Leader and Senior Scientist roles. Pui holds a Doctor of Philosophy in Organic Chemistry and a Bachelor of Applied Science in Chemistry, both obtained from Queen's University Belfast.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.